Clinical trial Recruiting at 1 site Interventional Ages 18 to 38

Low Volume Nose Breathing Exercises With an Incentive Spirometer for Cervical Spinal Cord Injury Patients

Official title: Effect of Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer on Pulmonary Function Test, Dyspnea, Cough and Sputum in Patient With Cervical Spinal Cord Injuries

Run by Riphah International University · NCT07645027 · Data updated 2026-11-12

This trial tests whether adding low-volume nose resistance breathing with an incentive spirometer to standard respiratory therapy helps people with cervical spinal cord injury breathe better.

Quick facts

Study typeInterventional
Ages18 Years to 38 Years
SexAll
Enrollment42 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedMay 1, 2026
Main results expectedAugust 1, 2026
Study endsAugust 1, 2026
Registry record updatedJune 12, 2026
Trial IDNCT07645027 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are inpatients aged 18–38 with recent cervical SCI (C4–C7), within one year of injury, able to consent, and without severe pulmonary disease.

Probably not a fit

Patients with longer-standing injury, severe comorbidities, or contraindications to pulmonary interventions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two respiratory rehabilitation strategies for adults with cervical spinal cord injury (C4–C7) in inpatient rehab. Group A receives low-volume nose resistance breathing exercises using an Acapella device plus incentive spirometry for 20 minutes, three times daily, five days a week, over four weeks; Group B receives conventional respiratory physiotherapy with the same frequency and duration. Outcomes include pulmonary function test results, dyspnea, cough effectiveness, and sputum characteristics, measured before and after the intervention. Statistical analyses will assess intra- and intergroup differences, with a significance level of p < 0.05. The study aims to determine if the LVNRBE plus IS approach provides added benefits over standard therapy in this population.

Why it matters

Potential benefit: If successful, patients may experience improved lung function, reduced dyspnea, and better airway clearance.

How similar studies have gone: Previous pulmonary rehabilitation efforts with breathing exercises and incentive devices have shown respiratory benefits in similar populations, but this specific LVNRBE plus IS combination is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagonosed cervical spine injury C4-C7
* Age 18-38 years
* Undergoing in-patient rehabilitation
* No previous history of severe pulmonary disease
* Disease duration \<1 year
* Ability to give informed consent
* Road Accident

Exclusion Criteria:

* Uncontrolled hypertension
* Other Neuromuscular disease
* Stage 3-4 pressure wound
* Clinical instability
* Traumatic Brain injury

Where it's running

  • Jinnah hoapital
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Arjumand Bano, MS — Riphah International University
  • Study coordinator: Muhammad Iqbal Tariq, Phd
  • Email: iqbal.tariq@riphah.edu.pk
  • Phone: 333826752

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.